Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
7
×
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
7
×
texas blog main
texas top stories
wisconsin blog main
7
×
wisconsin top stories
biotech
boston top stories
deals
fda
cancer immunotherapy
pfizer
abbvie
alzheimer's disease
cancer
clinical trials
eli lilly
europe blog main
europe top stories
What
bio
roundup
drug
acquisitions
alzheimer’s
amid
bombast
cancer
caught
ceo
coronavirus
daniel
debate
develop
discussion
efforts
gilead
meso’s
miss
o’day
pandemic
pfizer’s
presidential
promise
response
sciences
tuesday’s
vaccine
viewers
week
announced
annual
approved
assessed
attention
biggest
biotech
build
buy
collabs
Language
unset
Current search:
astrazeneca
×
startups
×
" wisconsin blog main "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More